Spin-outs come of age
publication date: May 23, 2006
Europe is buzzing with new companies spun out from universities, offering all manner of products and services to the life sciences industry. One such company is making a name for itself on the international circuit, with a disruptive technology for the analysis of macromolecules. Tim Lloyd met with Anthony Baxter, CEO of deltaDOT, to find out why now is the time for spin-outs to shine.
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.
Why should I register online with European Pharmaceutical Review?
